Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis

Academic Article

Abstract

  • OBJECTIVE: Studies suggest that circulating type I interferon (IFN) may predict response to biological agents in rheumatoid arthritis (RA). Prediction of response prior to initiating therapy would represent a major advancement.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Wampler Muskardin T; Vashisht P; Dorschner JM; Jensen MA; Chrabot BS; Kern M; Curtis JR; Danila MI; Cofield SS; Shadick N
  • Start Page

  • 1757
  • End Page

  • 1762
  • Volume

  • 75
  • Issue

  • 10